Aim: Group B streptococcus (GBS) is a leading cause of life-threatening bacterial infections among newborns, and neonates born to heavily colonized women may be subject to vertical transmission. We sought to determine an appropriate detection method for genital GBS in pregnant women by comparing culture-based methods and real-time polymerase chain reaction (PCR). In addition, we performed molecular serotyping and multilocus sequence typing (MLST) on isolates. Methods: A total of 150 pregnant women were enrolled and underwent vaginal-rectal swabbing at 16-40 weeks of gestation. GBS was identified by conventional culture and real-time PCR with or without enrichment. Molecular serotyping and MLST were performed on isolates. Results: Overall genital GBS positive rate among the 150 study subjects was 17.3%. Direct culture identified 18 (12.0%) positive specimens, enrichment culture 22 (14.6%), direct PCR 24 (16.0%) and enrichment PCR 25 (16.6%). The sensitivity and specificity by direct and enrichment PCR were as follows: for direct PCR, 90.9% and 96.9%, respectively; and for enrichment PCR, 95.5% and 96.9%, respectively. Resistance rates to clindamycin and erythromycin were 33.3% and 19.1%, respectively. Serotype III-1 was the most common (26.3%), followed by serotype Ib (21.1%), III-3 (15.8%), V (15.8%), II (10.5%), IV (5.3%) and VI (5.3%). Most common sequence types (ST) were ST-1, ST-19 and ST-862 (15.8%), followed by ST-2 and ST-654 (10.5%). Conclusion: Direct real-time PCR using vaginal-rectal specimen could be used for detecting GBS in emergent conditions. Molecular serotypes III, Ib and V were most common. MLST analysis frequently presented ST-1, 
Introduction
Group B streptococcus (GBS) is a leading cause of lifethreatening bacterial infections among newborns. Neonates born to heavily colonized women are associated to higher rates of vertical transmission and colonization at multiple sites. 1 Furthermore, women colonized with GBS have a significantly higher rates of premature rupture of membranes (PROM), postpartum fever and endometritis. 2 The current guidelines issued by the Centers for Disease Control and Prevention (CDC) for preventing neonatal GBS disease are screening pregnant women at 35-37 weeks of gestation to determine the presence of vaginal-rectal GBS colonization and the administration of intravenous intrapartum antibiotic prophylaxis (IAP) when colonization is detected. 3 The CDC recommends both the lower vagina and rectum be swabbed, and that samples be incubated in enrichment broth for ≥18 h at 35 C to 37 C. Following enrichment, conventional culture-based methods are performed to identify strains and antimicrobial susceptibilities with or without the nucleic acid amplification testing. Capsular polysaccharide (CPS) GBS serotype is one of the most important virulence factors involved in virulence, and its distribution depends on onset of neonatal disease, pregnancy and region. 2, 4 CPS type has also been used in epidemiologic studies of GBS, and 10 serotypes have been described. Furthermore, this type has been associated with antimicrobial susceptibility, and could be essential for the development of vaccines. 4, 5 Recently, multilocus sequence typing (MLST) has also been used to investigate population structures and genetic lineages of human bacterial pathogens. Approximately 500-bp fragments of seven housekeeping genes of GBS have been used for this purpose (collected data is available on the MLST website: https://pubmlst.org/sagalactiae). 6 In Korea, the genital GBS carrier rate was 2.3% in 1998, which was considerably lower than rates reported in the West. 2, 7 However, maternal GBS carrier rate seem to have increased recently in Korea, and relatively few studies have been performed on the topic. [8] [9] [10] [11] Primary aim of this study was to identify an appropriate method for detecting GBS by comparing culture-based methods and real-time polymerase chain reaction (PCR). In addition, we undertook the molecular serotyping and MLST of GBS isolates.
Methods

Patients and samples
A total of 150 pregnant women, who underwent GBS screening in Gachon University Gil Medical Center from July to December 2016, were enrolled. This study was prospectively conducted with remnant specimens for conventional culture. Specimens were obtained at 16-40 (mean, 30 + 1) weeks gestation for prenatal or intrapartum care. Combined vaginal-rectal specimens were obtained using nylon flocked swabs and 1 mL of liquid Amies transport medium (ESwab; Copan Diagnostics Inc.). All collected specimens were stored at 4 C when immediate laboratory processing was not possible. This study was approved by the Institutional Review Board of Gachon University Gil Medical Center (No. GBIRB2016-170).
Identification of GBS using a conventional culture-based method
Culture-based test results were considered positive if a GBS colony was identified in at least one of four of following plates: direct sheep blood agar plate (BAP), enrichment BAP, direct chromID Strepto B agar (CA; BioMérieux) and enrichment CA. All ESwab tubes were mixed using vortex mixer for 10 s to release specimens from swab tips and to disperse specimens in liquid transport medium. This medium was then directly inoculated onto BAP using a swab, and an aliquot of 50 μL of liquid transport medium was inoculated onto CA without enrichment (Fig. 1) . 12 An aliquot of 200 μL of liquid transport medium was also inoculated into Todd-Hewitt broth (Asan Pharm) supplemented with colistin (10 μg/dL) and nalidixic acid (15 μg/dL), and this mixture was enriched by incubating it for ≥18 h at 36 C according to CDC recommendations. 3, 13 Following enrichment, 50 μL of Todd-Hewitt broth was inoculated onto both BAP and CA after vortexing. Inoculated BAP and CA were incubated at 36 C in 5% CO 2 for 24 h, and inspected for characteristic GBS colonies. β-Hemolytic colonies on BAP or pale pink to red colonies on CA were viewed as suggestive of the presence of GBS. If a GBS colony was not identified, plates were reincubated for 24 h and reinspected. When suspected colonies were present, subculture was conducted for GBS identification by Lancefield grouping using type B antisera (Pastorex strep; BioRad) and Vitek 2 (BioMérieux). All GBS isolates also tested antibiotic susceptibility using Vitek 2. β-Hemolytic colonies were inspected after incubation in 5% CO 2 for 24 h at 36 C.
Identification of GBS using real-time PCR (BD Max assay)
On the first day, direct PCR was conducted using the BD Max assay (BD Diagnostic Systems) without enrichment using Todd-Hewitt broth (Fig. 1) . A 200 μL of ESwab transport medium, which was the same volume for enrichment, was mixed with BD Max sample preparation reagent and processed on the BD Max system using the BD Max assay. After 24-h enrichment, enrichment PCR was conducted according to manufacturer's recommendations. An aliquot of 15 μL of Todd-Hewitt broth was added to BD Max sample preparation reagent and processed on the BD Max system using the BD Max assay.
Molecular serotyping of GBS
Previously described oligonucleotide primers (Tables 1  and S1 , Supporting Information) were used for PCR and sequencing. 14, 15 All primers were synthesized by Bioneer, and DNA was extracted from single colonies by boiling for 15 min in 50 μL distilled water. PCR amplifications were performed in a total volume of 20 μL containing 2 μL of DNA template, 1 μL of forward and of reverse primers and PCR premix (Bioneer). Reactions were conducted using the following conditions: denaturation at 94 C for 1 min, annealing at 56 C for 1 min and extension at 72 C for 1 min for 35 cycles. Sequencing reactions to identify molecular serotypes were performed by Macrogen Inc. using same primer pair (cpsES3-cpsGA1) used for PCR. Molecular serotyping was determined using the previously reported heterogeneity of the partial cps sequence. 14, 16 However, the primer pair cpsES3-cpsGA1 was unable to distinguish Ia from III-3 or II from III-4. For these isolates, PCR was reperformed using another three primer pairs, that is, IacpsHS1-cpsIA, IIcpsKAp-IIcpsKSp and IIIcpsHScpsIA, and subsequent agarose gel electrophoresis. The VIIIcpsJAp-VIIIcpsJSp primer pair was used to detect serotypte VIII, which was not distinguishable based on the previously reported heterogeneity of the partial cps sequence.
MLST of GBS
MLST was performed as previously described using seven housekeeping genes. 6 PCR was performed in the manner described above for molecular serotyping. Sequencing reaction was also performed by Macrogen Inc. Unique allele numbers and sequence types (ST) were provided by the generated sequences of the seven genes from MLST databases (http://pubmlst. org/sagalactiae). The eBURST program (Department of Infections Disease Epidemiology of Imperial College London, London, UK) was used to group isolates into clonal complexes (http://eburst.mlst.net).
Statistical analysis
Statistical analysis was performed using SPSS statistics 24 (IBM Corporation). Fisher's exact test and MannWhitney test were used to compare sample distributions. Sensitivities and specificities of direct and enrichment PCR compared to culture-based method IacpsHS1  Ia  AB028896  8463-GGCCTGCTGGGATTAATGAATATAGTTCCAGGTTTGC-8499  cpsIA  Ia  AB028896  8816-GTATAACTTCTATCAATGGATGAGTCTGTTGTAGTACGG-8778  IIcpsKAp  II  AY375362  7420-GAAGATAACGAATACACCCCG-7440  IIcpsKSp  II  AY375362  7640-GAGCAGATGGAGAAGCTATTTC-7619  IIIcpsHS  III  AF163833  7672-GAATACTATTGGTCTGTATGTTGGTTTTATTAGCATCGC-7710  cpsIA  III  AF163833  8312-GTATAACTTCTATCAATGGATGAGTCTGTTGTAGTACGG-8274  VIIIcpsJAp  VIII  AY375363  5722-CTTGCAATTTGTGATCCAGTT-5742  VIIcpsJSp  VIII  AY375363 5956-GCATTACTGCGCTATCTTCA-5937 †Numbers represent the numbered base position at which primer sequences start and finish.
were calculated. The significances of differences between the sensitivities and specificities of direct PCR and enrichment PCR were calculated using the McNemar test. Statistical significance was accepted for P value less than 0.05.
Results
Of the 150 study subjects, 26 (17.3%) had positive GBS results by culture-based method and/or realtime PCR (Table 2 ). The sensitivity and specificity of direct PCR were 90.9% and 96.9% as compared with culture-based method, which was considered the gold standard method, and the sensitivity and specificity of enrichment PCR were 95.5% and 96.9% (Table 3) . Differences between the sensitivity and specificity of direct and enrichment PCR were not statistically significant (P = 1.000). Twenty-one isolates from 22 culture positive pregnant women were used for antimicrobial susceptibility testing. All isolates were susceptible to penicillin-G and vancomycin. Resistance rates to tetracycline, clindamycin, erythromycin and levofloxacin were 47.6%, 33.3%, 19.1% and 19.1%, respectively (Table S2) .
Nineteen isolates from 22 culture positive pregnant women were identified by molecular serotyping. The distribution of GBS molecular serotypes as determined by PCR in descending frequency order was as follows: serotype III-1 in five (26.3%) isolates, serotype Ib in four (21.1%) isolates, serotype III-3 in three (15.8%) isolates, serotype V in three (15.8%) isolates, serotype II in two (10.5%) isolates and serotype IV and VI in one (5.3%) isolates each (Table 4 ). Antibiotic resistance rates by serotype are summarized in Fig. 2 .
Nineteen isolates were also subjected to MLST and resolved into 11 ST and four clonal complexes. The molecular serotype distributions of ST are provided in Table 4 .
A total of 150 study subjects underwent GBS screening, and 99 returned to give birth. Seventeen of the 99 were positive for GBS by culture or real-time PCR. GBS positive pregnant women had PROM more frequently than GBS negative pregnant women (52.9% vs 23.2%, P < 0.05; Table 5 ). No significant differences were observed between GBS positive and GBS negative pregnant women in terms of maternal age at screening, gestational age at delivery, cesarean section rate, preterm labor, Apgar score or birthweight. No case of neonatal GBS disease was found in either group.
Discussion
In the present study, the overall genital GBS positive rate was 17.3%. Previously reported GBS positive rates among pregnant Korean women were 4.8% by enrichment culture using a cotton swab, and 6.2% by enrichment PCR using a cotton swab. 8, 9 Hong et al.
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reported GBS positive rates of 4.0% and 10% for vaginal specimens and vaginal and/or anorectal specimens, respectively. The CDC currently recommends vaginal-rectal specimens to determine the presence of GBS colonization in pregnant women. The higher GBS positive rate obtained in the present study might be related to sample collection and detection methods. In particular, the study was performed by real-time PCR using vaginal-rectal specimens obtained using ESwabs, which have been reported to increase the sensitivity for GBS screening, and at a tertiary hospital, which cares for a higher proportion of complicated cases. 17, 18 PCR methods have reported to have higher sensitivity and detection rates than conventional screening culture, which is viewed as the gold standard method for GBS detection. [19] [20] [21] [22] [23] [24] Previous studies were reported sensitivities for culture were 42.3-68.4%, whereas sensitivity of PCR was 99.6%. 25, 26 In the present study, the sensitivity and specificity of direct PCR and enrichment PCR were also excellent as compared with the culture-based method. Twenty-four (16.0%) pregnant women were positive by direct PCR and 25 (16.6%) were positive by enrichment PCR, whereas only 22 (14.6%) pregnant women were positive by culture (Table 3) . Although GBS positive rates of BAP and CA cultures increased to 14.6% and 13.3%, respectively, after enrichment, direct PCR detected more GBS positive specimens (16.0%) than enrichment BAP and CA cultures (14.6% and 13.3%, respectively; Table 2 ). Furthermore, the sensitivities and specificities of direct PCR and enrichment PCR were not significantly different, even though their determined sensitivities were 90.5% and 95.5%; this difference was probably caused by the small sample size. Recently, Ellem et al. also demonstrated that the direct BD Max GBS assay offered viable alternative to the current CDC recommended screening culture-based method, but they detected one more GBS isolates by enrichment culture than direct BD Max assay unlike that found in the present study. 27 Direct PCR could reduce the turnaround time for GBS detection by up to 3 h, which is very important when the patient concerned has not undergone prenatal screening at the time of delivery. More rapid and sensitive methods for the detecting GBS would aid decision-making regarding IAP during delivery. Furthermore, in the present study, 9 of 17 GBS positive pregnant women also had PROM (Table 5) , which is consistent with that observed in a previous study, in which pregnant women colonized with GBS were found to have significantly higher frequencies of PROM, postpartum fever, and endometritis.
2 PROM is also a recognized risk factor of early-onset neonatal GBS infection. 1 Therefore, a rapid and precise detection tool for GBS is needed when PROM occurs and no prenatal GBS screening test has been performed. Other have shown intrapartum molecular testing is superior to antenatal culture, and suggested a rapid and precise intrapartum test would be useful to prevent neonatal GBS infection. 17, [28] [29] [30] In Korea, the genital GBS carrier rate was thought of as low, and prenatal GBS screening tests were not in force either. Seventeen of 26 GBS positive pregnant women gave birth in Gachon University Gil Medical Center, and there was no adverse neonatal outcome in this study (Table 5 ). Among the 17 pregnant women, 10 were empirically treated with cefotetan for PROM, fever or cesarean section. One GBS carrier underwent ampicillin as an intravenous IAP. The rest six GBS positive pregnant women were not medicated antibiotic prophylaxis agents because they only underwent intrapartum tests by reason of early gestational weeks or new patients at the time of delivery. Maternal GBS carrier rate has been increasing in Korea, and GBS screening test of Korean pregnant women at 35-37 weeks' gestation and following IAP are necessary.
In this study, CA culture did not more effectively detect GBS than BAP culture although it has been reported to produce fewer false negatives and have a higher detection rate. 31 Furthermore, after enrichment, CA culture detected 20 (13.3%) positive samples, whereas BAP culture detected 22 (14.6%; Table 2 ). Although the sample size was small in the present study, this result should be considered by laboratories that operate according to self-generated guidelines for the detection of GBS.
One culture-positive sample was not detected by either direct or enrichment PCR ( Table 2 ). The repeated tests showed same results. Cultured colonies were also performed PCR but showed negative result. This isolate was identified as GBS by both Vitek 2 and 16S rRNA gene sequencing. This condition may be due to primer mismatches or mutation located on the hybridization region of the primer. In order to find cause of a false-negative result, further evaluations such as sequencing on cfb gene of this specimen were necessary.
The antimicrobial susceptibility testing is important for the selection of antibiotics for penicillin-allergic women at high risk for neonatal GBS disease. Furthermore, serotype III and V are related to macrolide resistance, and their proportions appear to be increasing. 11, 32 Uh and colleagues reported most erythromycin-resistant isolates had ermB or mefA genes. 33 In the present study, the resistance rate to erythromycin was 19.1%, which is lower than those previously reported in Korea, though 29.8% of isolates were intermediate to erythromycin. The antibiotic resistance rate found for clindamycin was also lower than reported previously, and serotypes III-1 and V showed had high drug resistant rates against erythromycin and clindamycin (Fig. 2) . For erythromycin, the resistance rate of serotype III-1 (40.0%) was lower than that of serotype V (66.7%). Lee et al. reported 78.1% of serotype V was resistant to erythromycin and clindamycin, but that only 12.0% of serotype III exhibited resistance to erythromycin and that 71.0% of serotype III was resistant to clindamycin in the previous Korean study. 34 In this study, the resistance rate to levofloxacin among the four serotype Ib isolates was 75.0%, and serotype Ib isolates were assigned to ST-8, ST-10 and ST-654, which were involved in clonal complex 10. Ryu et al. reported that levofloxacin resistant GBS from bacteremic patients in Korea was significantly predominant in clonal complex 10. 35 The CPS is a major virulence factor in invasive GBS disease and is commonly used in epidemiologic studies of GBS. A commercial latex agglutination method is commonly used for strain typing. However, latex agglutination is labor-intensive, only moderately reliable and requires high-titer serotypespecific antisera, the latter of which are expensive and not commercially available for subtypes of serotype III. On the other hand, molecular serotyping has been developing rapidly and exhibits high discriminatory power and reproducibility.
14 Multiplex PCR for GBS molecular serotyping is also available, and molecular serotyping and phenotypic methods have shown excellent concordance of up to 99%. [36] [37] [38] In the present study, eight (42.1%) isolates were assigned to serotype III (III-1, five isolates; III-3, three isolates), which was the most common type, and is inline with previous Korean reports (Table S3) . 9, 34 Serotypes V and Ib were also commonly observed, but there was no serotype Ia, which was observed up to 26.2% in a previous report. 9, 34, 39 On the other hand, serotype IV was detected in one (5.3%) isolate in the present study, and there were no serotype IV in previous three reports. GBS prevalence and serotype distributions depend on study region. In a previous study in Korea, GBS prevalence was 10.5% in Seoul and 4.6% in Daejun, and serotype III had a higher prevalence rate in Daejun than Seoul (56.9% vs 40.7%), serotype V had a higher prevalence rate in Seoul than Daejun (22.9% vs 13.5%). 34 In this study, which was performed at a tertiary hospital in Incheon, the rates of serotypes III, Ib and V were 42.1%, 21.1% and 15.8%, respectively.
Serotype distributions of early onset neonatal GBS disease from pregnant women in Korea also differed from those reported elsewhere; among infant cases, the most common was serotype III (35.7%), followed by serotypes V and Ia (21.4%), Ib (14.3%) and VI (7.2%). 40 Serotypes Ia, Ib, II, III and V are known to predominate in North America and Europe, whereas serotypes VI and VIII are more frequently found in Japan. [41] [42] [43] These differences should be considered when developing conjugate polysaccharide GBS vaccines for specific countries. Furthermore, larger-scale epidemiologic study of GBS strain is required in Korea.
This study is the first MLST study on GBS in pregnant Korean women. The most common ST found were ST-1, ST-19 and ST-862, whereas ST-1 and ST-19 were found to be the most common in previous studies conducted elsewhere. 6, 44 ST-862 was first reported at Singapore in 2015 from http://pubmlst.org/ sagalactiae, but was not found in two subsequent reports. All three ST-862 were correlated with serotype III-3 in this study.
In conclusion, real-time PCR method was faster and more sensitive than conventional culture, and the positive rates of direct PCR and enrichment PCR were similar. The study suggests direct real-time PCR could be very useful during emergent conditions, such as preterm labor or PROM for detecting GBS using vaginal-rectal specimens, especially in women who have not undergone prenatal screening. In the present study, the overall genital GBS carrier rate among 150 pregnant Korean women was 17.3%. Resistance rates to clindamycin and erythromycin were 33.3% and 19.1%. Molecular serotype III was the most common, followed by serotypes Ib and V. MLST analysis showed that ST-1, ST-19 and ST-862 predominated. However, the number of isolates was relatively small, and thus, further larger-scale, genetic epidemiologic studies are necessary.
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